Holdings of Global X Aging Population ETF
GLOBAL X FUNDS · Original filing · Compare with another fund · Report an error
- Net assets
- 89.3M $ including 89.1M $ in equities, 99.8 %
- Positions
- 80 in 18 countries
- Top ten
- 34.9 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | UCB SA | 12,486 | 3.7M $ | 4.17 % |
| 2 | Johnson & Johnson | 13,355 | 3.3M $ | 3.72 % |
| 3 | AstraZeneca PLC | 15,434 | 3.2M $ | 3.60 % |
| 4 | Roche Holding AG | 6,477 | 3.2M $ | 3.60 % |
| 5 | Merck & Co Inc | 25,377 | 3.1M $ | 3.52 % |
| 6 | Welltower Inc | 14,679 | 3M $ | 3.41 % |
| 7 | Chugai Pharmaceutical Co Ltd | 45,175 | 3M $ | 3.39 % |
| 8 | Eli Lilly & Co | 2,759 | 2.9M $ | 3.25 % |
| 9 | Regeneron Pharmaceuticals, Inc. | 3,596 | 2.8M $ | 3.15 % |
| 10 | Amgen Inc | 7,146 | 2.8M $ | 3.11 % |
| 11 | AbbVie Inc | 11,405 | 2.6M $ | 2.96 % |
| 12 | Edwards Lifesciences Corp | 29,871 | 2.6M $ | 2.89 % |
| 13 | Medtronic PLC | 24,413 | 2.4M $ | 2.67 % |
| 14 | Bristol-Myers Squibb Co | 37,666 | 2.3M $ | 2.63 % |
| 15 | Stryker Corp | 5,937 | 2.3M $ | 2.58 % |
| 16 | Sandoz Group AG | 25,830 | 2.3M $ | 2.56 % |
| 17 | Ventas Inc | 25,564 | 2.2M $ | 2.47 % |
| 18 | Celltrion Inc | 12,920 | 2.1M $ | 2.40 % |
| 19 | Alcon AG | 23,512 | 2M $ | 2.29 % |
| 20 | BEONE MEDICINES LTD | 5,772 | 1.8M $ | 2.05 % |
| 21 | Astellas Pharma Inc | 106,129 | 1.8M $ | 1.98 % |
| 22 | Boston Scientific Corp | 22,060 | 1.7M $ | 1.90 % |
| 23 | Dexcom Inc | 22,920 | 1.7M $ | 1.89 % |
| 24 | Hansoh Pharmaceutical Group Co Ltd | 347,443 | 1.6M $ | 1.74 % |
| 25 | United Therapeutics Corp | 2,628 | 1.3M $ | 1.48 % |
| 26 | Novo Nordisk A/S | 31,530 | 1.2M $ | 1.33 % |
| 27 | Terumo Corp | 86,865 | 1.2M $ | 1.31 % |
| 28 | Incyte Corp | 11,319 | 1.1M $ | 1.28 % |
| 29 | Zimmer Biomet Holdings Inc | 11,625 | 1.1M $ | 1.28 % |
| 30 | Genmab A/S | 3,892 | 1.1M $ | 1.27 % |
| 31 | Straumann Holding AG | 9,351 | 1.1M $ | 1.26 % |
| 32 | Exact Sciences Corp | 10,862 | 1.1M $ | 1.26 % |
| 33 | Insulet Corp | 4,115 | 1M $ | 1.14 % |
| 34 | Smith & Nephew PLC | 51,300 | 945.9K $ | 1.06 % |
| 35 | Sonova Holding AG | 3,499 | 918.6K $ | 1.03 % |
| 36 | Fresenius Medical Care AG | 17,202 | 801.2K $ | 0.90 % |
| 37 | Omega Healthcare Investors Inc | 16,468 | 794.9K $ | 0.89 % |
| 38 | Neurocrine Biosciences Inc | 5,821 | 769.8K $ | 0.86 % |
| 39 | CG oncology Inc | 12,816 | 753.6K $ | 0.84 % |
| 40 | DaVita Inc | 4,668 | 729.6K $ | 0.82 % |
| 41 | Exelixis Inc | 16,332 | 719.6K $ | 0.81 % |
| 42 | Ensign Group Inc/The | 3,338 | 714.9K $ | 0.80 % |
| 43 | Brookdale Senior Living Inc | 38,990 | 596.5K $ | 0.67 % |
| 44 | Cochlear Ltd | 3,858 | 547.2K $ | 0.61 % |
| 45 | Halozyme Therapeutics Inc | 7,213 | 501.5K $ | 0.56 % |
| 46 | Theravance Biopharma Inc | 24,020 | 438.4K $ | 0.49 % |
| 47 | LivaNova PLC | 5,889 | 415.8K $ | 0.47 % |
| 48 | Glaukos Corp | 3,296 | 396.8K $ | 0.44 % |
| 49 | Demant A/S | 12,535 | 389.8K $ | 0.44 % |
| 50 | Denali Therapeutics Inc | 17,433 | 369.2K $ | 0.41 % |
| 51 | National HealthCare Corp | 2,240 | 366.2K $ | 0.41 % |
| 52 | ACADIA Pharmaceuticals Inc | 14,178 | 348.2K $ | 0.39 % |
| 53 | Microport Scientific Corp | 232,802 | 325.6K $ | 0.36 % |
| 54 | Teleflex Inc | 2,600 | 317.4K $ | 0.36 % |
| 55 | Sienna Senior Living Inc | 18,000 | 309.9K $ | 0.35 % |
| 56 | Chartwell Retirement Residences | 17,919 | 291.9K $ | 0.33 % |
| 57 | Alphatec Holdings Inc | 21,191 | 288.6K $ | 0.32 % |
| 58 | Sabra Health Care REIT Inc | 13,924 | 286.1K $ | 0.32 % |
| 59 | Luye Pharma Group Ltd | 855,624 | 283.3K $ | 0.32 % |
| 60 | Aedifica SA | 3,008 | 279.3K $ | 0.31 % |
| 61 | Ypsomed Holding AG | 801 | 278.1K $ | 0.31 % |
| 62 | Elekta AB | 41,973 | 270K $ | 0.30 % |
| 63 | Merit Medical Systems Inc | 3,456 | 266.7K $ | 0.30 % |
| 64 | Agios Pharmaceuticals Inc | 8,124 | 245.6K $ | 0.28 % |
| 65 | National Health Investors Inc | 2,916 | 245.1K $ | 0.27 % |
| 66 | Lifetech Scientific Corp | 1,160,792 | 243.4K $ | 0.27 % |
| 67 | LTC Properties Inc | 6,095 | 241.8K $ | 0.27 % |
| 68 | Nipro Corp | 22,569 | 229.9K $ | 0.26 % |
| 69 | Pharma Mar SA | 2,414 | 228.7K $ | 0.26 % |
| 70 | Clariane SE | 47,052 | 226.1K $ | 0.25 % |
| 71 | GN Store Nord AS | 15,094 | 223.4K $ | 0.25 % |
| 72 | AK Medical Holdings Ltd | 263,689 | 217.1K $ | 0.24 % |
| 73 | Ryman Healthcare Ltd | 140,981 | 210.6K $ | 0.24 % |
| 74 | Amplifon SpA | 13,290 | 206.7K $ | 0.23 % |
| 75 | Novocure Ltd | 13,030 | 178.1K $ | 0.20 % |
| 76 | Embecta Corp | 17,331 | 177.8K $ | 0.20 % |
| 77 | Integer Holdings Corp | 1,938 | 168K $ | 0.19 % |
| 78 | Dentium Co Ltd | 4,154 | 145.8K $ | 0.16 % |
| 79 | MannKind Corp | 43,279 | 142K $ | 0.16 % |
| 80 | agilon health Inc | 36,470 | 21.5K $ | 0.02 % |
Sector breakdown
- Health care 51.1 %
- Real estate 5.9 %
- Unattributed 43.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 64.1 %
- CHF 11.1 %
- JPY 7.0 %
- EUR 6.1 %
- DKK 3.3 %
- HKD 2.9 %
- KRW 2.6 %
- GBP 1.1 %
- CAD 0.7 %
- AUD 0.6 %
- SEK 0.3 %
- NZD 0.2 %
The quoted currency of each line, as declared.
Country breakdown
- United States 60.3 %
- Switzerland 11.1 %
- Japan 7.0 %
- United Kingdom 4.7 %
- Belgium 4.5 %
- Denmark 3.3 %
- South Korea 2.6 %
- Cayman Islands 2.0 %
- Hong Kong SAR China 1.0 %
- Germany 0.9 %
- Canada 0.7 %
- Australia 0.6 %
- Other countries 1.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 45 | 53.7M $ | 60.32 % |
| 2 | Switzerland | 6 | 9.9M $ | 11.07 % |
| 3 | Japan | 4 | 6.2M $ | 6.96 % |
| 4 | United Kingdom | 2 | 4.2M $ | 4.67 % |
| 5 | Belgium | 2 | 4M $ | 4.49 % |
| 6 | Denmark | 4 | 2.9M $ | 3.30 % |
| 7 | South Korea | 2 | 2.3M $ | 2.57 % |
| 8 | Cayman Islands | 2 | 1.8M $ | 1.99 % |
| 9 | Hong Kong SAR China | 3 | 852.3K $ | 0.96 % |
| 10 | Germany | 1 | 801.2K $ | 0.90 % |
| 11 | Canada | 2 | 601.8K $ | 0.68 % |
| 12 | Australia | 1 | 547.2K $ | 0.61 % |
Cite this page
Titelia. "Holdings of Global X Aging Population ETF". https://titelia.com/en/funds/S000054162